DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

K-TAB (Potassium Chloride) - Adverse Event Reports - Life Threatening Events - Hyperkalaemia

 



Index of reports > Cases resulting in life threatening events (1) > Cases with Hyperkalaemia (1)

Below is the selection of adverse event reports related to K-TAB (Potassium Chloride) that includes cases resulting in life threatening events where reactions include hyperkalaemia.

Adverse event in 73 year old male receiving K-TAB (Potassium Chloride)

Reported by a physician from United States on 2007-04-26

Patient: 73 year old male

Adverse reactions / side effects: Mean Arterial Pressure Decreased, Dyspnoea, Hyperkalaemia, Atrioventricular Block Complete, Atrial Fibrillation, Bradycardia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Dabigatran Etexilate
    Indication: Drug USE FOR Unknown Indication

K-TAB
    Indication: Electrolyte Substitution Therapy
    Start date: 2007-03-07
    End date: 2007-03-29

Spironolactone
    Indication: Cardiac Failure Congestive
    Start date: 2006-05-14
    End date: 2007-03-29

Other drugs received by patient: Bumetanide; Lisinopril

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009